All articles tagged with #novo
Originally Published 2 months ago — by Seeking Alpha
Pfizer has matched Novo Nordisk's bid for the obesity biotech Metsera amid a fierce takeover battle, highlighting the competitive interest in the obesity treatment sector.
Originally Published 2 months ago — by Financial Times
Pfizer has matched Novo Nordisk's bid for the obesity biotech Metsera amid a fierce takeover competition, highlighting the high stakes in the biotech industry.
Originally Published 5 months ago — by Barron's
A proposed Trump administration plan to allow Medicare and Medicaid to cover obesity drugs like Lilly's Zepbound and Novo's Wegovy could benefit these companies, but high list prices remain a significant barrier. The plan's details are unclear, and cost concerns persist, with estimates suggesting substantial increases in federal spending if coverage expands. The move could improve access for many obese patients but faces skepticism from investors due to potential cost implications.
Originally Published 2 years ago — by Yahoo Finance
Novo, the maker of Ozempic, experienced a drop in its stock price after its first stock split in a decade.